| Diversity and evolution of class 2 CRISPR–Cas systems S Shmakov, A Smargon, D Scott, D Cox, N Pyzocha, W Yan, ... Nature reviews microbiology 15 (3), 169-182, 2017 | 1071 | 2017 |
| Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28 AA Smargon, DBT Cox, NK Pyzocha, K Zheng, IM Slaymaker, ... Molecular cell 65 (4), 618-630. e7, 2017 | 596 | 2017 |
| Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity P Lee, J Waalen, K Crain, A Smargon, E Beutler Blood Cells, Molecules, and Diseases 39 (3), 353-360, 2007 | 79 | 2007 |
| RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering AA Smargon, YJ Shi, GW Yeo Nature cell biology 22 (2), 143-150, 2020 | 66 | 2020 |
| Novel crispr enzymes and systems AA Smargon, F Zhang US Patent App. 15/331,792, 2017 | 65 | 2017 |
| Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing F Zhang, W Yan, DA Scott, A Smargon, MR Mirzazadeh, N Crosetto US Patent 10,689,691, 2020 | 60 | 2020 |
| Rna-targeting system F Zhang, P Hsu, JS Gootenberg, A Smargon US Patent App. 15/632,067, 2017 | 39 | 2017 |
| Systems and methods for customized multimedia surveys in a social network environment A Smargon US Patent App. 13/411,418, 2012 | 37 | 2012 |
| Detection of intrinsic cluster alignments to 100 h−1 Mpc in the Sloan Digital Sky Survey A Smargon, R Mandelbaum, N Bahcall, M Niederste-Ostholt Monthly Notices of the Royal Astronomical Society 423 (1), 856-861, 2012 | 37 | 2012 |
| Methods for identifying class 2 crispr-cas systems S Shmakov, KS Makarova, YI Wolf, A Smargon, N Pyzocha, D Cox, W Yan, ... US Patent App. 16/326,132, 2021 | 25 | 2021 |
| Systems and methods for transactions and rewards in a social network A Smargon US Patent App. 13/411,408, 2012 | 17 | 2012 |
| Engineered U1 snRNAs to modulate alternatively spliced exons ST Hatch, AA Smargon, GW Yeo Methods 205, 140-148, 2022 | 8 | 2022 |
| Crosstalk between CRISPR-Cas9 and the human transcriptome AA Smargon, AA Madrigal, BA Yee, KD Dong, JR Mueller, GW Yeo Nature communications 13 (1), 1125, 2022 | 7 | 2022 |
| Novel crispr enzymes and systems F Zhang, A Smargon, N Pyzocha, DBT Cox, ES Lander US Patent App. 15/960,064, 2019 | 3 | 2019 |
| Type vi-b crispr enzymes and systems F Zhang, A SMARGON, N PYZOCHA, DBT Cox, ES Lander | 2 | 2018 |
| Detection of intrinsic cluster alignments to 100 Mpc/h in the SDSS A Smargon, R Mandelbaum, N Bahcall, M Niederste-Ostholt arXiv preprint arXiv:1109.6020, 2011 | 1 | 2011 |
| Small nuclear RNAs enhance protein-free RNA-programmable base conversion on mammalian coding transcripts AA Smargon, D Pant, S Glynne, TA Gomberg, EW Yeo bioRxiv, 2024.06. 12.598766, 2024 | | 2024 |
| Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders KH Morelli, AA Smargon, GW Yeo RNA 29 (4), 489-497, 2023 | | 2023 |
| Discovery and characterization of Cas13b, a differentially regulated RNA-targeting CRISPR system AA Smargon Massachusetts Institute of Technology, 2018 | | 2018 |
| An expanded search for RNA-programmable genomic engineering effectors AA Smargon Massachusetts Institute of Technology, 2016 | | 2016 |
